Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kellie Young"'
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-4 (2021)
Abstract Background There is rising utilization of immune checkpoint inhibitors (ICI) for a growing number of metastatic malignancies. While gastrointestinal side effects of ICI are common, isolated ICI-induced enteritis leading to small bowel hemorr
Externí odkaz:
https://doaj.org/article/f113406b485e40f6a26f0a883ddeb267
Publikováno v:
J Clin Exp Hepatol
BACKGROUND: Direct-acting antivirals (DAAs) are expected to improve outcomes for patients with hepatitis C virus (HCV) infection after liver transplantation (LT). We aim to evaluate trends in post-LT outcomes with availability of DAAs. METHODS: We re
Publikováno v:
Journal of Viral Hepatitis. 26:350-361
Direct-acting antiviral (DAA) therapies for chronic hepatitis C virus (HCV) infection achieve high cure rates, reducing HCV-related disease progression to cirrhosis and hepatocellular carcinoma. We aim to evaluate the impact of DAAs on US liver trans
Autor:
Robert J. Wong, Kellie Young
Publikováno v:
Clinical Liver Disease. 10:152-156
Autor:
Aijaz Ahmed, Benny Liu, Kellie Young, Zobair M. Younossi, Robert J. Wong, Sammy Saab, Taft Bhuket
Publikováno v:
Journal of Viral Hepatitis. 24:789-796
With effective antiviral therapies, rates of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and decompensated liver disease requiring liver transplantation (LT) are expected to decrease. We aim to evaluate overall trends in LT waitlis
Autor:
Kellie Young, Andrew D. Ho
Publikováno v:
American Journal of Gastroenterology. 112:S381-S382
Publikováno v:
Gastroenterology. 152:S1120-S1121
Publikováno v:
Gastroenterology. 154:S-1103
Autor:
Maria Aguilar, Robert G. Gish, Zobair M. Younossi, Benny Liu, Kellie Young, Robert J. Wong, Sammy Saab, Taft Bhuket, Aijaz Ahmed
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 22(10)
Receiving Model for End-Stage Liver Disease (MELD) exception status for hepatocellular carcinoma (HCC) improves wait-list survival and probability of liver transplantation (LT). We aim to evaluate etiology-specific disparities in MELD exception, LT w
Autor:
Maureen P. Kohi, Francis Y. Yao, Kellie Young, Nancy K. Hills, Andrew Taylor, Robert K. Kerlan, K. Pallav Kolli, Nicholas Fidelman
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol 21, iss 4
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide.1 Treatment options depend on the tumor stage and liver function.2 Resection, thermal ablation, and liver transplantation are the only potentially curative o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1029cc6733976ba52be65da75481602
https://escholarship.org/uc/item/7429j0jq
https://escholarship.org/uc/item/7429j0jq